JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M310821200 on October 23, 2003

J. Biol. Chem., Vol. 279, Issue 1, 288-298, January 2, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/1/288    most recent
M310821200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tang, C.-H.
Right arrow Articles by Grimm, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, C.-H.
Right arrow Articles by Grimm, E. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Depletion of Endogenous Nitric Oxide Enhances Cisplatin-induced Apoptosis in a p53-dependent Manner in Melanoma Cell Lines*

Chi-Hui Tang{ddagger} and Elizabeth A. Grimm§

From the University of Texas Graduate School of Biomedical Sciences and the Department of Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

The expression of inducible nitric-oxide synthase in melanoma tumor cells was recently shown to correlate strongly with poor patient survival after combination biochemotherapy (p < 0.001). Furthermore, evidence suggests that nitric oxide, a reaction product of nitricoxide synthase, exhibits antiapoptotic activity in melanoma cells. We therefore hypothesized that nitric oxide antagonizes chemotherapy-induced apoptosis. Whether nitric oxide is capable of regulating cell growth and apoptotic responses to cisplatin treatment in melanoma cell lines was evaluated. We demonstrate herein that depletion of endogenously produced nitric oxide can inhibit melanoma proliferation and promote apoptosis. Moreover, our data indicate that the depletion of nitric oxide leads to changes in cell cycle regulation and enhances cisplatin-induced apoptosis in melanoma cells. Strikingly, we observed that the depletion of nitric oxide inhibits cisplatin-induced wild type p53 accumulation and p21Waf1/Cip1/Sdi1 expression in melanoma cells. When cisplatin-induced p53 binding to the p21Waf1/Cip1/Sdi1 promoter was examined, it was found that nitric oxide depletion significantly reduced the presence of p53-DNA complexes after cisplatin treatment. Furthermore, dominant negative inhibition of p53 activity enhanced cisplatin-induced apoptosis. Together, these data strongly suggest that endogenously produced nitric oxide is required for cisplatin-induced p53 activation and p21Waf1/Cip1/Sdi1 expression, which can regulate melanoma sensitivity to cisplatin.


Received for publication, October 1, 2003 , and in revised form, October 22, 2003.

* This work was supported in part by the National Institutes of Health Grant R01 CA90282 (to E. A. G.), a Rosalie B. Hite Research Fellowship (to C.-H. T.), Department of Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center and Health Science Center, Houston, and The University of Texas Graduate School of Biomedical Sciences, Houston. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Partial fulfillment of the requirements for a Ph.D. degree.

§ To whom correspondence should be addressed. Tel.: 713-792-3667; Fax: 713-792-2070; E-mail: egrimm{at}mdanderson.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
C.-H. Tang, J.-W. Lee, M. G. Galvez, L. Robillard, S. E. Mole, and H. A. Chapman
Murine cathepsin f deficiency causes neuronal lipofuscinosis and late-onset neurological disease.
Mol. Cell. Biol., March 1, 2006; 26(6): 2309 - 2316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Jiang, X. Yi, S. Hsu, C.-Y. Wang, and Z. Dong
Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity
Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1140 - F1147.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. S. Lind
Arginine and Cancer
J. Nutr., October 1, 2004; 134(10): 2837S - 2841S.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Matsunaga, S. Kotamraju, S. V. Kalivendi, A. Dhanasekaran, J. Joseph, and B. Kalyanaraman
Ceramide-induced Intracellular Oxidant Formation, Iron Signaling, and Apoptosis in Endothelial Cells: PROTECTIVE ROLE OF ENDOGENOUS NITRIC OXIDE
J. Biol. Chem., July 2, 2004; 279(27): 28614 - 28624.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.